| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |